Market Overview:
The global drug device combination products market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in drug delivery devices. Based on type, the global drug device combination products market is segmented into drug-eluting stents, prefilled syringes, wearable injectors, insulin injector drugs and others. Drug-eluting stents are expected to account for the largest share of this market in 2018 owing to their high adoption rates across various applications such as hospitals and clinics. By application, hospitals are expected to account for the largest share of this market in 2018 followed by clinics and ambulatory surgical centers (ASCs). Geographically, North America is estimated to dominate the global drug device combination products market in 2018 followed by Europe and Asia Pacific.
Product Definition:
A drug-device combination product is a product composed of two or more regulated products, where at least one of the products is a drug and at least one is a device.
Drug-Eluting Stents:
Drug-eluting stents are used to treat coronary artery disease by reducing the inflammation and damage to the heart muscle caused by arteries. The drug-eluting stent market is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence of cardiovascular diseases, technological advancements in manufacturing processes, rising awareness about minimally invasive procedures among patients & physicians and increasing healthcare expenditure in developed countries.
Prefilled Syringes:
Prefilled syringes are used in the drug-device combination product manufacturing process. They help in reducing the time and cost required for filling a pre-filled syringe by eliminating human intervention that is involved with manual preparation of an injection. The device consists of a housing, which contains a mechanism to push back the plunger after pressing inject button; this allows loading of liquid into vial or glass container through needle without any further assistance from person.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and ambulatory surgical centers, other institutions. Hospitals held the largest revenue share in 2017 owing to factors such as a high prevalence of target diseases and increasing number of procedures per year. According to WHO, around 1 in 6 deaths occur due to cardiovascular diseases globally. Thus, an increase in the incidence rate of target diseases increases hospital admissions which further drives demand for drug combination products used for cardiac care.
The other institutions segment is expected to witness significant growth over the forecast period owing to growing awareness about availability of advanced healthcare facilities at low cost coupled with technological advancements that have made it easier for patients with diabetes or hypertension or hyperlipidemia etc.,to access these services without having a stay overnight at hospital or clinic premises.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement policies, increasing healthcare expenditure, and rising incidence of cardiovascular diseases & target diseases. Moreover, presence of key players in this region is expected to drive the market further. For instance, Boston Scientific Corporation; Medtronic; BMS; Johnson & Johnson Services Inc.; and Novo Nordisk A/S are some of the major players operating in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing demand for advanced medical devices coupled with a high prevalence rate for chronic conditions like diabetes & cardiac disorders that require long-term therapy (stents). In addition, economic development has led to an increase in disposable income which will eventually lead towards an increase in product adoption rates over next eight years from 2018 till 2030 time frame.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The rise in the number of people suffering from chronic diseases has led to a corresponding increase in demand for drug device combination products.
- Technological advancements: Drug device combination products are becoming increasingly complex as manufacturers strive to develop innovative and more effective products. This has led to significant advancements in technology, which are helping to improve the efficacy and safety profile of these products.
- Growing demand for personalized medicine: There is a growing trend towards personalized medicine, where patients receive treatments that are tailored specifically for them based on their individual genetic makeup or health condition. Drug device combination products offer great potential for personalization, as they can be customized according to the specific needs of each patient.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Device Combination Products Market Research Report
By Type
Drug-Eluting Stents, Prefilled Syringes, Wearable Injectors, Insulin Injector Drug, Others
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Others
By Companies
Abbott Laboratories, Terumo, Stryker, Mylan, Medtronic, Allergan,, Boston Scientific, Novartis, Teleflex, BD, W.L.Core & Associates, Gerresheimer, Schott, Nipro
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Drug Device Combination Products Market Report Segments:
The global Drug Device Combination Products market is segmented on the basis of:
Types
Drug-Eluting Stents, Prefilled Syringes, Wearable Injectors, Insulin Injector Drug, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Terumo
- Stryker
- Mylan
- Medtronic
- Allergan,
- Boston Scientific
- Novartis
- Teleflex
- BD
- W.L.Core & Associates
- Gerresheimer
- Schott
- Nipro
Highlights of The Drug Device Combination Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug-Eluting Stents
- Prefilled Syringes
- Wearable Injectors
- Insulin Injector Drug
- Others
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Device Combination Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug device combination products are a type of medical device that combines two or more devices to treat a single condition. Drug device combination products can be used to improve the effectiveness of treatment by combining different types of devices into one product.
Some of the major companies in the drug device combination products market are Abbott Laboratories, Terumo, Stryker, Mylan, Medtronic, Allergan,, Boston Scientific, Novartis, Teleflex, BD, W.L.Core & Associates, Gerresheimer, Schott, Nipro.
The drug device combination products market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Device Combination Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug Device Combination Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug Device Combination Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug Device Combination Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug Device Combination Products Market Size & Forecast, 2018-2028
4.5.1 Drug Device Combination Products Market Size and Y-o-Y Growth
4.5.2 Drug Device Combination Products Market Absolute $ Opportunity
Chapter 5 Global Drug Device Combination Products Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Device Combination Products Market Size Forecast by Type
5.2.1 Drug-Eluting Stents
5.2.2 Prefilled Syringes
5.2.3 Wearable Injectors
5.2.4 Insulin Injector Drug
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Device Combination Products Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Device Combination Products Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Device Combination Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Device Combination Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Device Combination Products Analysis and Forecast
9.1 Introduction
9.2 North America Drug Device Combination Products Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Device Combination Products Market Size Forecast by Type
9.6.1 Drug-Eluting Stents
9.6.2 Prefilled Syringes
9.6.3 Wearable Injectors
9.6.4 Insulin Injector Drug
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Device Combination Products Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Device Combination Products Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Device Combination Products Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Device Combination Products Market Size Forecast by Type
10.6.1 Drug-Eluting Stents
10.6.2 Prefilled Syringes
10.6.3 Wearable Injectors
10.6.4 Insulin Injector Drug
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Device Combination Products Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Device Combination Products Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Device Combination Products Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Device Combination Products Market Size Forecast by Type
11.6.1 Drug-Eluting Stents
11.6.2 Prefilled Syringes
11.6.3 Wearable Injectors
11.6.4 Insulin Injector Drug
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Device Combination Products Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Device Combination Products Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Device Combination Products Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Device Combination Products Market Size Forecast by Type
12.6.1 Drug-Eluting Stents
12.6.2 Prefilled Syringes
12.6.3 Wearable Injectors
12.6.4 Insulin Injector Drug
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Device Combination Products Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Device Combination Products Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Device Combination Products Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Device Combination Products Market Size Forecast by Type
13.6.1 Drug-Eluting Stents
13.6.2 Prefilled Syringes
13.6.3 Wearable Injectors
13.6.4 Insulin Injector Drug
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Device Combination Products Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Device Combination Products Market: Competitive Dashboard
14.2 Global Drug Device Combination Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Terumo
14.3.3 Stryker
14.3.4 Mylan
14.3.5 Medtronic
14.3.6 Allergan,
14.3.7 Boston Scientific
14.3.8 Novartis
14.3.9 Teleflex
14.3.10 BD
14.3.11 W.L.Core & Associates
14.3.12 Gerresheimer
14.3.13 Schott
14.3.14 Nipro
